Conference abstract · 23 Sep 2013
Conference abstractPublished 23 Sep 2013
Patent litigation issues surrounding biologics
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
It is characteristic of any emerging field of technology that innovators seek to claim as much operating space as possible through patent protection. Biologics patents are no exception but there are downsides to claiming too broadly. Patent law imposes its own constraints and there are special considerations under biotech legislation. The reported UK patent litigation cases provide an insight into the issues that arise with biologics, both in terms of the validity of patents for biologics and their interpretation for the purposes of assessing infringement. Biologic products also raise interesting issues in relation to the rapidly-developing law on supplementary protection certificates-European patent term extensions for medicinal products-reflecting the difficulty of accurately characterizing biologic products. The commercial and regulatory landscape for biosimilar products is such that patent litigation in the UK and Europe is still in its infancy but predictions can be made based on the cases heard by the courts to date and from the uncertainties arising within the framework of legal rules designed to cope with this rapidly developing area of technology.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 25 Jun 2013
The what million dollar question: Patent litigation and strategy under the Biologics Price Competition and Innovation Act
Conference abstract
The what million dollar question: Patent litigation and strategy under the Biologics Price Competition and Innovation Act
Conference abstract · 23 Sep 2013
Patent issues for biologic and biosimilar products
Research article · 31 May 2014
Pharmaceutical patent infringement litigation warning indicator system
More from this journal
The newest in Journal of Bioanalysis & Biomedicine.
Article · 29 Dec 2025
Label-Free Biosensing: Revolutionizing Disease Detection and Drug Discovery
Article · 29 Dec 2025
Epigenetic Modifications: Bioanalysis for Disease and Therapeutics
Article · 29 Dec 2025
Advancing Bioanalysis: New Tech, AI, and Precision Medicine
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioanalysis & Biomedicine
- BylineArticles whose byline prints “Dominic E. Adair”

